Multi-kinase-IN-2

Multi-kinase-IN-2 is an orally bioavailable small molecule inhibitor targeting key angiokinases including VEGFR, PDGFR, FGFR-1, LYN, and c-KIT. It demonstrates anticancer activity by suppressing AKT/ERK phosphorylation and inducing apoptosis, as shown in relevant in vitro and in vivo cancer research models.